1 – 10 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
- Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial.
- Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: a perspective from the EBMT cell-processing committee.
- 2013
- Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT
- Management of acquired aplastic anemia in children
- Potential adult sibling stem cell donors' perceptions and opinions regarding an information and care model.
- 2012
- The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries
- Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy
- 2011
- Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder
- 2010
- CD146 expression of primary bone marrow MSC progenitor/stem cells is regulated by hypoxia and correlates with in vivo location
- Ethical cafes strengthen the team spirit